EUVIMEDEUVIMED entdecken
Crossref

Long‐term clinical outcomes of healthy dogs with increased alanine aminotransferase

J Adams iD

Journal of Small Animal Practice · 2024

DOI: 10.1111/jsap.13777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Small Animal Practice, 2024. Verfasst von J Adams. Beteiligte Einrichtung: J Adams Locum Services Ltd, Lincoln, UK. Hauptthemen laut MEDLINE: Alanine Transaminase, Dog Diseases. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To define a reference interval for alanine aminotransferase for the practice laboratory and then identify and longitudinally follow the clinical health and alanine aminotransferase levels in a cohort of clinically healthy dogs with increased alanine aminotransferase levels documented during wellness screening. Materials and Methods Alanine aminotransferase levels of 125 clinically healthy dogs were used to define a reference interval for the practice laboratory. The electronic records of 315 clinically healthy dogs which had undergone wellness screening including assessment of alanine aminotransferase levels at a first‐opinion veterinary hospital in the UK were reviewed between January 2012 and January 2023. Clinically healthy dogs with increased alanine aminotransferase levels relative to the top of the reference interval determined for the practice on at least one test during the study period were identified. These were longitudinally followed through electronic medical records to determine their long‐term clinical outcomes over a period of up to 11 years.

Results

The reference interval for alanine aminotransferase in the practice laboratory was calculated as 10.6 to 181.8 U/L. Nineteen clinically healthy dogs were identified as having increased alanine aminotransferase levels. One dog from the group with increased alanine aminotransferase levels was diagnosed with chronic hepatitis and died of liver failure, while the other 18 dogs died of other causes, or were still alive at the end of the study, with no clinical signs associated with liver disease. One dog in the group with consistently normal alanine aminotransferase levels also died from clinical signs attributed to liver disease. Clinical Significance Only a small proportion of clinically healthy dogs with increased alanine aminotransferase levels documented on wellness screening developed clinically relevant liver dysfunction over long‐term follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alanine TransaminaseDog DiseasesAnimalsDogsReference ValuesMaleFemaleLiver DiseasesLongitudinal Studies

Substanzen

Alanine Transaminase

Autor:innen und Institutionen

  • J Adams Locum Services Ltd, Lincoln, UK.

ORCID-Profile: J Adams

Zitieren

APA

Adams, J. (2024). Long‐term clinical outcomes of healthy dogs with increased alanine aminotransferase. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13777

Vancouver

Adams J. Long‐term clinical outcomes of healthy dogs with increased alanine aminotransferase. Journal of Small Animal Practice. 2024. doi:10.1111/jsap.13777

BibTeX
@article{Adams2024,
  author = {Adams, J},
  title = {Long‐term clinical outcomes of healthy dogs with increased alanine aminotransferase},
  journal = {Journal of Small Animal Practice},
  year = {2024},
  doi = {10.1111/jsap.13777}
}
Kostenlos starten →